Phibro Animal Health CORP Schedule 13G passive stakes

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 15.0% of Phibro Animal Health Corp's Class A Common Stock as of June 30, 2026.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.1% of Phibro Animal Health Corporation's Class A Common Stock.

Barclays PLC has filed a Schedule 13G disclosing a 1.27% beneficial ownership stake in Phibro Animal Health Corp.

Vanguard Capital Management has reported beneficial ownership of 5.06% of Phibro Animal Health Corp.'s common stock as of March 31, 2026.

FMR LLC, along with Abigail P. Johnson, has reported beneficial ownership of 2,173,126.20 shares, representing 10.5% of Phibro Animal Health Corp's Class A Common Stock as of March 31, 2026.

The Vanguard Group has reported a 0% beneficial ownership in Phibro Animal Health Corp common stock following an internal realignment.

Barclays PLC has reported a 5.1% beneficial ownership stake in Phibro Animal Health Corp-A, totaling 1,042,888 common shares.

Pzena Investment Management LLC has filed an amended Schedule 13G, reporting a 3.6% beneficial ownership stake in Phibro Animal Health Corp's Class A common stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reporting a 15.7% beneficial ownership stake in Phibro Animal Health Corp's Class A Stock as of March 31, 2025.

Brandes Investment Partners and affiliated entities have disclosed a passive beneficial ownership of 3.26% in Phibro Animal Health Corporation's common stock as of December 31, 2024.

Brandes Investment Partners, along with affiliated entities and Glenn Carlson, has filed an amended Schedule 13G, reporting a beneficial ownership of 10.48% in Phibro Animal Health Corporation as of December 31, 2024.